Ankur A Dashputre
Overview
Explore the profile of Ankur A Dashputre including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
80
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lacy B, Gagnon-Sanschagrin P, Heimanson Z, Bungay R, Bellefleur R, Guerin A, et al.
Adv Ther
. 2024 Apr;
41(6):2253-2266.
PMID: 38619720
Introduction: Objective assessment of treatment effectiveness using real-world claims data is challenging. This study assessed treatment-free intervals (TFI) as a proxy for treatment effectiveness, and all-cause healthcare costs among adult...
2.
Harper J, Baldwin H, Choudhury S, Rai D, Ghosh B, Aman M, et al.
J Drugs Dermatol
. 2024 Apr;
23(4):216-226.
PMID: 38564399
Background: Multiple treatment options exist for the management of moderate-to-severe acne. However, the comparative effectiveness (efficacy/safety) of moderate-to-severe acne treatments has not been systematically examined. Methods: A systematic literature review...
3.
Obi Y, Thomas F, Dashputre A, Goedecke P, Kovesdy C
Kidney Med
. 2024 Jan;
6(1):100757.
PMID: 38192434
Rationale & Objective: Patiromer is a potassium binder approved for the long-term management of hyperkalemia. Although patiromer use among patients with advanced chronic kidney disease (CKD) has been shown to...
4.
Gold L, Harding G, Borroto D, Choudhury S, Dutta S, PharmD T, et al.
J Drugs Dermatol
. 2023 Oct;
22(10):1033-1039.
PMID: 37801539
Acne has psychosocial effects on patient's quality of life (QoL). This post hoc exploratory analysis of pooled phase 3 data assessed the impact of investigational IDP-126 gel (for moderate to...
5.
Jesudian A, Gagnon-Sanschagrin P, Heimanson Z, Bungay R, Chen J, Guerin A, et al.
J Med Econ
. 2023 Sep;
26(1):1169-1177.
PMID: 37664993
Aim: To assess the impact of rifaximin (± lactulose) use following discharge of an initial overt hepatic encephalopathy (OHE) hospitalization on OHE rehospitalizations and healthcare costs in a real-world setting....
6.
Durgam N, Dashputre A, Moshkovich O, Rezaie A, Martinez N, Enayati P, et al.
Qual Life Res
. 2023 May;
32(9):2573-2585.
PMID: 37212941
Purpose: The aim of this study was to generate evidence supporting the development and content validity of a new PRO instrument, the Small Intestinal Bacterial Overgrowth (SIBO) Symptom Measure (SSM)...
7.
Potukuchi P, Moradi H, Park F, Kaplan C, Thomas F, Dashputre A, et al.
Cannabis Cannabinoid Res
. 2021 Oct;
8(1):138-147.
PMID: 34597156
The current social and legal landscape is likely to foster the medicinal and recreational use of cannabis. Synthetic cannabinoid use is associated with acute kidney injury (AKI) in case reports;...
8.
Dashputre A, Gatwood J, Sumida K, Thomas F, Akbilgic O, Potukuchi P, et al.
J Manag Care Spec Pharm
. 2021 Oct;
27(10):1403-1415.
PMID: 34595956
Patients with advanced chronic kidney disease (CKD) are at high risk for dyskalemias, which may induce arrhythmias that require immediate emergent or hospital care. The association of dyskalemias with short-term...
9.
Surbhi S, Tolley E, Cossman R, Dashputre A, Bailey J
MethodsX
. 2021 Aug;
8:101299.
PMID: 34434819
This article describes a rationale and approach for modifying the traditional rural-urban commuting area (RUCA) coding scheme used to classify U.S. ZIP codes to enable suburban/rural vs. urban core comparisons...
10.
Dashputre A, Sumida K, Thomas F, Gatwood J, Akbilgic O, Potukuchi P, et al.
Am J Nephrol
. 2021 Jul;
52(7):539-547.
PMID: 34289468
Introduction: Hypo- and hyperkalemia are associated with a higher risk of ischemic stroke. However, this association has not been examined in an advanced chronic kidney disease (CKD) population. Methods: From...